Back to search
FDAFDA · Food and drugs·Recall number D-0015-2026

Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1

Published October 22, 2025 · Recall initiated: September 16, 2025

Summary

FDA records drug Class I recall D-0015-2026, published October 22, 2025 and initiated September 16, 2025. Recalling firm: IntegraDose Compounding Services LLC; Status: Ongoing; Reported quantity: 853/500 mL bags; Lot: Lot #: 20250620OXY-1, Expiration date 10/18/2025. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
IntegraDose Compounding Services LLC
Distributor
Nationwide in the USA
Lot
Lot #: 20250620OXY-1, Expiration date 10/18/2025
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1 recalled?

Yes. FDA published recall D-0015-2026 on October 22, 2025. Reported hazard: Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.

What should I do if I have this product?

Voluntary: Firm initiated · Letter